Drug class
Topical imidazole antifungal
Mechanism of action
As an imidazole antifungal, eberconazole is understood to inhibit fungal ergosterol biosynthesis through interference with lanosterol 14α-demethylase, disrupting fungal cell-membrane integrity; the specific molecular contribution of each pathway has not been fully characterised in the cited clinical trial.
General use cases
- Topical treatment of dermatophytoses
- Topical use has also been reported for cutaneous candidiasis and pityriasis; exact indications depend on the locally authorised formulation
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
